Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
    1.
    发明申请
    Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds 失效
    哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合咪唑环化合物

    公开(公告)号:US20070167476A1

    公开(公告)日:2007-07-19

    申请号:US10596895

    申请日:2004-12-22

    IPC分类号: A61K31/4745 C07D487/22

    CPC分类号: C07D471/14 C07D471/04

    摘要: Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds (i.e., imidazoquinolines, tetrahydroimidazoquinolines, imidazonaphthyridines, tetrahydroimidazonaphthyridines, and imidazopyridines), pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

    摘要翻译: 哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合的咪唑环化合物(即咪唑并喹啉,四氢咪唑并喹啉,咪唑并噻嗪,四氢咪唑并萘啶和咪唑并吡啶) 公开了制备方法以及这些化合物作为免疫调节剂用于诱导或抑制动物细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病的方法。